CLINICAL_TRIALS
research
· 2025-10-01
Clinical Trial Update: Oral Semaglutide in Patients With Alzheimer's Disease [Phase 2]
Summary
Phase 2 clinical trial evaluating oral semaglutide for Alzheimer disease; study not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Imperial College London | Conditions: Alzheimer Disease | Phase 2 | Status: NOT_YET_RECRUITING